Main findings and outcomes of matched patients with mAS and asAS, divided into HVC versus SOC
| HVC (n=156) | SOC (n=156) | P value | |
| Total cardiac consultation/year, n | 1.6±1 | 0.8±0.9 | <0.001 |
| Exercise stress/year, n | 0.5±0.3 | 0.2±0.4 | <0.001 |
| BNP determinations, n | 2.3±0.7 | 1.3±1.2 | <0.001 |
| No of CCT, n (%) | 41 (26.3) | 20 (12.8) | 0.002 |
| Calcium score, mean±SD | 2499±1708 | 1812±1232 | 0.413 |
| Time indication to AVR, months | 1.9±1 | 3.3±1.3 | <0.001 |
| NYHA class at AVR, n (%) | 0.032 | ||
| I–II | 38 (54.3) | 20 (33.9) | |
| III–IV | 32 (45.7) | 39 (66.1) | |
| AVR, n (%) | 70 (44.9) | 59 (37.8) | 0.250 |
| SAVR | 63 (90) | 54 (91.5) | 0.994 |
| TAVR | 7 (10) | 5 (8.5) | |
| HF readmission, n (%) | 36 (23.1) | 24 (15.4) | 0.114 |
| 1-year all-cause death, n (%)* | 4 (2.6) | 17 (11.3) | 0.003 |
Continuous variables are presented as mean (SD) or median (LQ–UQ), when indicated; categorical ones are represented as n (%).
*Differences in categorical variables were analysed using Fisher’s exact test.
asAS, asymptomatic severe aortic stenosis; AVR, aortic valve replacement; CCT, cardiac computed tomography; HF, heart failure; HVC, heart value clinic; LQ, lower quartile; mAS, moderate aortic stenosis; NYHA, New York Heart Association; SAVR, surgical aortic valve replacement; SOC, standard of care; TAVR, transcatheter aortic valve replacement; UQ, upper quartile.